社区
首页
集团介绍
社区
资讯
行情
学堂
TigerAI
登录
注册
信达生物(01801)
78.800
+2.550
+3.34%
行情数据延迟15分钟
社区
社区
资讯
资讯
资料
资料
公告
公告
最新
推荐
公司概况
公司名称
信达生物
所属市场
SEHK
成立日期
- -
员工人数
- -
办公地址
- -
公司网址
http://www.innoventbio.com
邮政编码
- -
联系电话
- -
联系传真
- -
公司概况
信达生物制药是一家主要从事研发、生产及销售治疗肿瘤、心血管及代谢（CVM）、自身免疫及眼科等重大疾病创新药物的投资控股公司。药物形式包括单克隆抗体、多特异性抗体、免疫细胞因子、抗体偶联药物（ADC）、细胞治疗及小分子药物等。该公司的主要产品包括达伯舒（信迪利单抗注射液）、达攸同（贝伐珠单抗注射液）、苏立信（阿达木单抗注射液）、达伯华（利妥昔单抗注射液）、达伯坦（佩米替尼片）等。该公司主要在中国国内和海外市场开展业务。
2025-12-05
股份发行
完成与武田制药的全球战略合作及根据一般授权发行股份
完成与武田制药的全球战略合作及根据一般授权发行股份
2025-10-22
股份发行
与武田制药达成全球战略合作及根据一般授权发行股份
与武田制药达成全球战略合作及根据一般授权发行股份
2025-09-29
半年度报告
2025 中期报告
2025 中期报告
2025-08-27
半年度报告
截至2025年6月30日止六个月中期业绩公告
截至2025年6月30日止六个月中期业绩公告
2025-07-04
股份发行
完成根据一般授权配售新股份
完成根据一般授权配售新股份
2025-06-26
股份发行
根据一般授权配售新股份
根据一般授权配售新股份
2025-06-02
股份购回
(1)建议授出购回股份及发行新股份的一般授权、(2)建议重选退任董事、(3)建议续聘外聘核数师、(4)授出受限制股份及(5)股东周年大会通告
(1)建议授出购回股份及发行新股份的一般授权、(2)建议重选退任董事、(3)建议续聘外聘核数师、(4)授出受限制股份及(5)股东周年大会通告
2025-04-29
年度报告
2024年报
2024年报
2025-03-26
年度报告
截至2024年12月31日止年度年度业绩公告
截至2024年12月31日止年度年度业绩公告
2024-09-27
半年度报告
2024 中期报告
2024 中期报告
2024-08-28
半年度报告
截至2024年6月30日止六个月中期业绩公告
截至2024年6月30日止六个月中期业绩公告
2024-05-29
股份购回
(1)建议授出购回股份及发行新股份的一般授权、(2)建议重选退任董事、(3)建议续聘外聘核数师、(4)建议采纳新组织章程及组织章程细则及(5)股东周年大会通告
(1)建议授出购回股份及发行新股份的一般授权、(2)建议重选退任董事、(3)建议续聘外聘核数师、(4)建议采纳新组织章程及组织章程细则及(5)股东周年大会通告
2024-04-29
年度报告
2023年报
2023年报
2024-03-20
年度报告
截至2023年12月31日止年度年度业绩公告
截至2023年12月31日止年度年度业绩公告
2023-09-27
半年度报告
2023 中期报告
2023 中期报告
加载更多
分时
5日
日
周
月
数据加载中...
最高
79.000
今开
77.400
量比
0.32
最低
76.750
昨收
76.250
换手率
0.23%
热议股票
{"pagemeta":{"title":"信达生物(01801)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供信达生物(01801)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"信达生物,01801,信达生物股票,信达生物股票老虎,信达生物股票老虎国际,信达生物行情,信达生物股票行情,信达生物股价,信达生物股市,信达生物股票价格,信达生物股票交易,信达生物股票购买,信达生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"信达生物(01801)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供信达生物(01801)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}},"tab":"fillings","symbol":"01801","data":{"stockData":{"symbol":"01801","market":"HK","secType":"STK","nameCN":"信达生物","latestPrice":78.8,"timestamp":1767341326003,"preClose":76.25,"halted":0,"volume":3960839,"delay":0,"floatShares":1721000000,"shares":1721000000,"eps":-0.06500298921631266,"marketStatus":"未开盘","change":2.55,"latestTime":"01-02 16:08:46","open":77.4,"high":79,"low":76.75,"amount":310179769,"amplitude":0.029508,"askPrice":78.8,"askSize":33500,"bidPrice":78.75,"bidSize":2500,"shortable":3,"etf":0,"ttmEps":0.754225169687242,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1767576600000},"marketStatusCode":0,"adr":0,"listingDate":1540915200000,"exchange":"SEHK","adjPreClose":76.25,"openAndCloseTimeList":[[1767317400000,1767326400000],[1767330000000,1767340800000]],"volumeRatio":0.31861971337235057,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD","optionSymbol":"INB.HK","impliedVol":0.4508,"impliedVolPercentile":0.122},"tweetData":null,"newsData":null,"noticeData":{"listData":[{"cdn_pdf":true,"hasAttachments":false,"id":"20491229","market":"hk","labels":[],"media":"港交所","original_id":"N.HK5VPvkYCi36","pdf_url":"https://static.tigerbbs.com/c60585da8148477fb1ac226aa012f6a3","pub_time":1764889200000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"完成与武田制药的全球战略合作及根据一般授权发行股份","symbol":"01801","title":"完成与武田制药的全球战略合作及根据一般授权发行股份","titleType":"股份发行","type":"hkShares","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2025/1205/2025120500042_c.pdf","us_notice_code":"公告及通告 - [其他-业务发展最新情况 / 代价发行 / 根据一般性授权发行股份]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"股权股本","type_name_en":"Equity Change","titleTypeEn":"Share Issuance","event_type":"important_notice","event_name":"股份发行","pubTime":"2025-12-05 07:00","pubTimestamp":1764889200,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"20286111","market":"hk","labels":[],"media":"港交所","original_id":"N.HKBE8WiVq2Br","pdf_url":"https://static.tigerbbs.com/d2163a6cc6064877bf4c87c46b177ce9","pub_time":1761090240000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"与武田制药达成全球战略合作及根据一般授权发行股份","symbol":"01801","title":"与武田制药达成全球战略合作及根据一般授权发行股份","titleType":"股份发行","type":"hkShares","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2025/1022/2025102200032_c.pdf","us_notice_code":"公告及通告 - [其他-业务发展最新情况 / 代价发行 / 根据一般性授权发行股份]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"股权股本","type_name_en":"Equity Change","titleTypeEn":"Share Issuance","event_type":"important_notice","event_name":"股份发行","pubTime":"2025-10-22 07:44","pubTimestamp":1761090240,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"20215773","market":"hk","labels":[],"media":"港交所","original_id":"N.HKHNZbsFsr9k","pdf_url":"https://static.tigerbbs.com/03f0f61a85d74a25ae641ded0bbf05e2","pub_time":1759134840000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"2025 中期报告","symbol":"01801","title":"2025 中期报告","titleType":"半年度报告","type":"hkFinancials","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2025/0929/2025092900685_c.pdf","us_notice_code":"财务报表/环境、社会及管治资料 - [中期/半年度报告]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Interim Report","event_type":"important_notice","event_name":"半年度报告","pubTime":"2025-09-29 16:34","pubTimestamp":1759134840,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"20067592","market":"hk","labels":[],"media":"港交所","original_id":"N.HK3KMpa4dHKT","pdf_url":"https://static.tigerbbs.com/d729445ec7784f21bdbbb21ed1a372c0","pub_time":1756287000000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"截至2025年6月30日止六个月中期业绩公告","symbol":"01801","title":"截至2025年6月30日止六个月中期业绩公告","titleType":"半年度报告","type":"hkFinancials","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2025/0827/2025082700861_c.pdf","us_notice_code":"公告及通告 - [中期业绩]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Interim Report","event_type":"important_notice","event_name":"半年度报告","pubTime":"2025-08-27 17:30","pubTimestamp":1756287000,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"19850150","market":"hk","labels":[],"media":"港交所","original_id":"N.HK8GJxKBHpiv","pdf_url":"https://static.tigerbbs.com/de1193217a344fc987716e69cad786c9","pub_time":1751624220000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"完成根据一般授权配售新股份","symbol":"01801","title":"完成根据一般授权配售新股份","titleType":"股份发行","type":"hkShares","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2025/0704/2025070401622_c.pdf","us_notice_code":"公告及通告 - [配售 / 根据一般性授权发行股份]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"股权股本","type_name_en":"Equity Change","titleTypeEn":"Share Issuance","event_type":"important_notice","event_name":"股份发行","pubTime":"2025-07-04 18:17","pubTimestamp":1751624220,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"19809002","market":"hk","labels":[],"media":"港交所","original_id":"N.HKAGyV1NMLXP","pdf_url":"https://static.tigerbbs.com/0381e4aac5144687b52d87024556c128","pub_time":1750892400000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"根据一般授权配售新股份","symbol":"01801","title":"根据一般授权配售新股份","titleType":"股份发行","type":"hkShares","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2025/0626/2025062600058_c.pdf","us_notice_code":"公告及通告 - [配售 / 根据一般性授权发行股份]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"股权股本","type_name_en":"Equity Change","titleTypeEn":"Share Issuance","event_type":"important_notice","event_name":"股份发行","pubTime":"2025-06-26 07:00","pubTimestamp":1750892400,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"19719119","market":"hk","labels":[],"media":"港交所","original_id":"N.HKGrh9Tc2sja","pdf_url":"https://static.tigerbbs.com/1b167ea61840443b8ecda16d99022955","pub_time":1748853060000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"(1)建议授出购回股份及发行新股份的一般授权、(2)建议重选退任董事、(3)建议续聘外聘核数师、(4)授出受限制股份及(5)股东周年大会通告","symbol":"01801","title":"(1)建议授出购回股份及发行新股份的一般授权、(2)建议重选退任董事、(3)建议续聘外聘核数师、(4)授出受限制股份及(5)股东周年大会通告","titleType":"股份购回","type":"hkShares","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2025/0602/2025060201539_c.pdf","us_notice_code":"通函 - [一般性授权 / 回购股份的说明函件 / 在股东批准的情况下重选或委任董事 / 股份计划]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"股权股本","type_name_en":"Equity Change","titleTypeEn":"Share Repurchase","event_type":"important_notice","event_name":"股份购回","pubTime":"2025-06-02 16:31","pubTimestamp":1748853060,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"19559840","market":"hk","labels":[],"media":"港交所","original_id":"N.HKDYHP1Nd6Z4","pdf_url":"https://static.tigerbbs.com/45239679cdbc49c3bb6ec7a4c8bab753","pub_time":1745877660000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"2024年报","symbol":"01801","title":"2024年报","titleType":"年度报告","type":"hkFinancials","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2025/0429/2025042900006_c.pdf","us_notice_code":"财务报表/环境、社会及管治资料 - [年报]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Annual Report","event_type":"important_notice","event_name":"年度报告","pubTime":"2025-04-29 06:01","pubTimestamp":1745877660,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"19285223","market":"hk","labels":[],"media":"港交所","original_id":"N.HKEvWZzHTkut","pdf_url":"https://static.tigerbbs.com/f6d18101d41b4c06aa1cd422c68b576d","pub_time":1742983200000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"截至2024年12月31日止年度年度业绩公告","symbol":"01801","title":"截至2024年12月31日止年度年度业绩公告","titleType":"年度报告","type":"hkFinancials","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2025/0326/2025032600778_c.pdf","us_notice_code":"公告及通告 - [末期业绩 / 暂停办理过户登记手续或更改暂停办理过户日期]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Annual Report","event_type":"important_notice","event_name":"年度报告","pubTime":"2025-03-26 18:00","pubTimestamp":1742983200,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"18653456","market":"hk","labels":[],"media":"港交所","original_id":"N.HKBpysHv493j","pdf_url":"https://static.tigerbbs.com/64afee5119ab429fbfe8e27aa5fb483d","pub_time":1727425800000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"2024 中期报告","symbol":"01801","title":"2024 中期报告","titleType":"半年度报告","type":"hkFinancials","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2024/0927/2024092700584_c.pdf","us_notice_code":"财务报表/环境、社会及管治资料 - [中期/半年度报告]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Interim Report","event_type":"important_notice","event_name":"半年度报告","pubTime":"2024-09-27 16:30","pubTimestamp":1727425800,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"18535578","market":"hk","labels":[],"media":"港交所","original_id":"N.HK8zmpE3sfp3","pdf_url":"https://static.tigerbbs.com/3b6863e51e9547c8986deafda72066f1","pub_time":1724839200000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"截至2024年6月30日止六个月中期业绩公告","symbol":"01801","title":"截至2024年6月30日止六个月中期业绩公告","titleType":"半年度报告","type":"hkFinancials","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2024/0828/2024082800859_c.pdf","us_notice_code":"公告及通告 - [中期业绩]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Interim Report","event_type":"important_notice","event_name":"半年度报告","pubTime":"2024-08-28 18:00","pubTimestamp":1724839200,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"18203087","market":"hk","labels":[],"media":"港交所","original_id":"N.HKFTt7UxYzh2","pdf_url":"https://static.tigerbbs.com/1757cce42cb14e83b27d7b7aba6af85c","pub_time":1716974700000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"(1)建议授出购回股份及发行新股份的一般授权、(2)建议重选退任董事、(3)建议续聘外聘核数师、(4)建议采纳新组织章程及组织章程细则及(5)股东周年大会通告","symbol":"01801","title":"(1)建议授出购回股份及发行新股份的一般授权、(2)建议重选退任董事、(3)建议续聘外聘核数师、(4)建议采纳新组织章程及组织章程细则及(5)股东周年大会通告","titleType":"股份购回","type":"hkShares","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2024/0529/2024052900595_c.pdf","us_notice_code":"通函 - [一般性授权 / 回购股份的说明函件 / 在股东批准的情况下重选或委任董事 / 修订宪章文件]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"股权股本","type_name_en":"Equity Change","titleTypeEn":"Share Repurchase","event_type":"important_notice","event_name":"股份购回","pubTime":"2024-05-29 17:25","pubTimestamp":1716974700,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"18070930","market":"hk","labels":[],"media":"港交所","original_id":"N.HK6WHJuufAzu","pdf_url":"https://static.tigerbbs.com/8fbd7d64267549b58c2df1e38a64c856","pub_time":1714401360000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"2023年报","symbol":"01801","title":"2023年报","titleType":"年度报告","type":"hkFinancials","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2024/0429/2024042905756_c.pdf","us_notice_code":"财务报表/环境、社会及管治资料 - [年报]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Annual Report","event_type":"important_notice","event_name":"年度报告","pubTime":"2024-04-29 22:36","pubTimestamp":1714401360,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"17729867","market":"hk","labels":[],"media":"港交所","original_id":"N.HKDNPCXTGmbM","pdf_url":"https://static.tigerbbs.com/1cea9b67a7d64d13b3cdedd78c06efdc","pub_time":1710930600000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"截至2023年12月31日止年度年度业绩公告","symbol":"01801","title":"截至2023年12月31日止年度年度业绩公告","titleType":"年度报告","type":"hkFinancials","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2024/0320/2024032000930_c.pdf","us_notice_code":"公告及通告 - [末期业绩 / 暂停办理过户登记手续或更改暂停办理过户日期]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Annual Report","event_type":"important_notice","event_name":"年度报告","pubTime":"2024-03-20 18:30","pubTimestamp":1710930600,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"17008548","market":"hk","labels":[],"media":"港交所","original_id":"N.HKK25objBeTt","pdf_url":"https://static.tigerbbs.com/748afeaa07074eea8e915f1a82431d4a","pub_time":1695804600000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"2023 中期报告","symbol":"01801","title":"2023 中期报告","titleType":"半年度报告","type":"hkFinancials","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2023/0927/2023092700710_c.pdf","us_notice_code":"财务报表/环境、社会及管治资料 - [中期/半年度报告]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Interim Report","event_type":"important_notice","event_name":"半年度报告","pubTime":"2023-09-27 16:50","pubTimestamp":1695804600,"notice_type":"","filling_tag":"","gpt_icon":0}],"currentPage":1,"bottom":false},"companyData":{"profile":{"websiteUrl":"http://www.innoventbio.com","stockEarnings":[{"period":"1week","weight":-0.0241},{"period":"1month","weight":-0.1416},{"period":"3month","weight":-0.1955},{"period":"6month","weight":-0.0858},{"period":"1year","weight":1.2197},{"period":"ytd","weight":0.0334}],"compareEarnings":[{"period":"1week","weight":0.0201},{"period":"1month","weight":0.0224},{"period":"3month","weight":-0.0296},{"period":"6month","weight":0.1013},{"period":"1year","weight":0.3422},{"period":"ytd","weight":0.0276}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"信达生物制药是一家主要从事研发、生产及销售治疗肿瘤、心血管及代谢（CVM）、自身免疫及眼科等重大疾病创新药物的投资控股公司。药物形式包括单克隆抗体、多特异性抗体、免疫细胞因子、抗体偶联药物（ADC）、细胞治疗及小分子药物等。该公司的主要产品包括达伯舒（信迪利单抗注射液）、达攸同（贝伐珠单抗注射液）、苏立信（阿达木单抗注射液）、达伯华（利妥昔单抗注射液）、达伯坦（佩米替尼片）等。该公司主要在中国国内和海外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.044847},{"month":2,"riseRate":0.714286,"avgChangeRate":0.11927},{"month":3,"riseRate":0.285714,"avgChangeRate":-0.021767},{"month":4,"riseRate":0.714286,"avgChangeRate":0.040816},{"month":5,"riseRate":0.428571,"avgChangeRate":0.027398},{"month":6,"riseRate":0.714286,"avgChangeRate":0.139165},{"month":7,"riseRate":0.428571,"avgChangeRate":0.010056},{"month":8,"riseRate":0.714286,"avgChangeRate":0.000214},{"month":9,"riseRate":0.571429,"avgChangeRate":0.032182},{"month":10,"riseRate":0.285714,"avgChangeRate":-0.02286},{"month":11,"riseRate":0.625,"avgChangeRate":0.079172},{"month":12,"riseRate":0.375,"avgChangeRate":0.024026}],"exchange":"SEHK","name":"信达生物","nameEN":"INNOVENT BIO"},"aProfile":null}}}